Silo Pharma share price logo

Silo Pharma

NASDAQ: SILO

$2.07

-0.03

(-1.43%)

as on

Silo Pharma Stock Performance

as on September 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.05
    $2.19
    downward going graph

    0.97%

    Downside

    5.80%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.05
    $15.15
    downward going graph

    0.97%

    Downside

    631.88%

    Upside

    downward going graph

Silo Pharma share price movements today

Previous Close
$2.10
Open
$2.09
Volume
199.7K
Market Cap
$3.7M
Day's Low - High
$2.05 - $2.19
52 Week Low - High
$2.05 - $15.15

Silo Pharma Historical Returns

1 Month Return
-35.31 %
3 Month Return
-67.3 %
1 Year Return
-82.77 %
3 Year Return
-92.54 %
5 Year Return
0 %

Silo Pharma Stock Fundamentals & Key Indicators

Check Silo Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-5.353

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.39

Industry PE ratio

-1.78

PEG Ratio

-0.003166790105016912

EBITDA

-4.6M

Revenue (TTM)

54.1K

Profit Margin

-474.31%

Return On Equity TTM

-81.74%

Silo Pharma Stock Valuation

Track how Silo Pharma P/E has moved over time to understand its valuation trends.

Silo Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-1.96x)

December 31, 2022

Industry (-1.78x)

December 31, 2025

Today (-0.68x)

December 31, 2025

Highest (0.07x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -0.68x

Silo Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silo Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Silo Pharma image
Silo Pharma
BUY$3.7MNA-0.39-474.31%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.6B175.08%29.7686.04%NA
Moderna image
Moderna
BUY$57.5B-66.24%-18.04-12.57%NA
Regeneron image
Regeneron
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Silo Pharma Stock including INR - Dollar returns

The Silo Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Silo Pharma investment value today

Current value as on today

₹18,686

Returns

-₹81,314

(-81.31%)

Returns from Silo Pharma Stock

-₹82,765 (-82.77%)

Dollar Impact

₹1,451 (+1.45%)

Analyst Recommendation on Silo Pharma Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Silo Pharma. Average target price of $10

Silo Pharma Share Price Target

Get share price movements and forecasts by analysts on Silo Pharma.

What analysts predicted

79.3%UPSIDE

Target Price

$10

Current Price

$2.07

Analyzed by

7 Analysts

Target

$10.00

Silo Pharma target price $10, a slight upside of 79.3% compared to current price of $2.07. According to 7 analysts rating.

Indian Investors' Interest in Silo Pharma Stock

Search interest for Silo Pharma Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Silo Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
-1
-1
-1
-1
-1
-1
0
-1
0
EBITDA
0
0
0
-1
-1
-1
-1
0
-1
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
-1
-1
-1
-1
0
-1
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
0
-1
-1
-1
-1
0
-1
0
Net Profit Margin
91.90%
91.91%
91.91%
-2118.26%
91.90%
91.91%
-14.77%
-14.77%
-1377.08%
0.00%

Silo Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
0
-
0
0
0
0
0
Gross Profit
0
0
0
-
0
0
0
0
0
Operating Income
0
0
0
-2
-2
-3
-3
-4
-4
EBITDA
0
0
0
-2
4
-3
-3
-4
-4
Interest Expense
-
-
0
0
0
0
0
0
0
Depreciation
-
0
-
-
-
-
-
0
0
Income Before Tax
0
0
-1
-2
4
-3
-3
-4
-4
Income Tax Expense
-
-
-
-
0
-
-
-
-
Net Income
0
0
-1
-3
3
-3
-3
-4
-4
Net Profit Margin
100.00%
0.00%
32.49%
0.00%
92.98%
91.90%
91.90%
91.90%
-1128.89%

Silo Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
-1
-1
1
-1
0
-1
0
Operating Cash Flow
0
0
-1
0
-1
-1
0
0
0
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
1
-
-
2
0
2
-
0
Change in Cash
0
1
0
0
0
1
0
0
0
0

Silo Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-1
-3
4
-3
-3
-4
-4
Operating Cash Flow
0
0
0
-1
-2
-3
-3
-3
-4
Investing Cash Flow
0
0
0
0
7
0
-4
0
0
Financing Cash Flow
-
0
0
2
3
4
0
3
4
Change in Cash
0
0
0
1
8
1
-7
0
0

Mutual Funds that own Silo Pharma Stock

Check out the Mutual Funds with significant holdings in Silo Pharma.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
5.550511%
88156
VANGUARD INDEX FUNDS
0.7065%
11221

Global Institutional Holdings in Silo Pharma

Funds
Holdings
Bruce Winson
59.96%
AdvisorShares
5.89%
Vanguard
0.75%

Silo Pharma News & Key Events

  • img

    Today's Timeline - 14 July

    Tue, 06:25 PM

    -

    Silo Pharma's QwikAgents accepted into AMD AI Developer Program, gaining access to advanced AI tools and resources.

    Tue, 09:15 PM

    -

    Silo Pharma shares fell 4.36% to $5.05 amid volatility following AI program announcement.

Insights on Silo Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.64M → -832.82K (in $), with an average increase of 97.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 18.02K → 18.02K (in $), with an average increase of 0.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 597.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 28.0% return, outperforming this stock by 120.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SILO stock has moved down by -35.3%

About Silo Pharma

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
OrganisationSilo Pharma
Headquarters677 North Washington Boulevard, Sarasota, FL, United States, 34236
IndustryBiotechnology
CEOMr. Eric Weisblum
E-voting on sharesClick here to vote

Key Management of Silo Pharma

Name

Title

Mr. Eric Weisblum

Chairman, President & CEO

Mr. Daniel E. Ryweck

Chief Financial Officer

FAQs

What is Silo Pharma share price today?

Silo Pharma share price today is $2.07 as on at the close of the market. Silo Pharma share today touched a day high of $2.19 and a low of $2.05.

What is the 52 week high and 52 week low for Silo Pharma share?

Silo Pharma share touched a 52 week high of $15.15 on and a 52 week low of $2.05 on . Silo Pharma stock price today i.e. is closed at $2.07,which is 86.34% down from its 52 week high and 0.98% up from its 52 week low.

What is Silo Pharma's market capitalisation today?

Silo Pharma market capitalisation is $0.00T as on .

How to invest in Silo Pharma Stock (SILO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Silo Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silo Pharma Shares that will get you 0.7246 shares as per Silo Pharma share price of $2.07 per share as on September 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Silo Pharma Stock (SILO) from India?

Indian investors can start investing in Silo Pharma (SILO) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Silo Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Silo Pharma share’s latest price of $2.07 as on September 15, 2026 at 8:46 am IST, you will get 4.8309 shares of Silo Pharma. Learn more about fractional shares .